Hyperekplexia mutation R271L of α1 glycine receptors potentiates allosteric interactions of nortropeines, propofol and glycine with [3H]strychnine binding

G. Maksay, Tímea Bíró, Bodo Laube, Péter Nemes

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Human α1 and hyperekplexia mutant α1(R271L) glycine receptors (GlyRs) were transiently expressed in human embryonic kidney 293 cells for [3H]strychnine binding. Binding parameters were determined using a ternary allosteric model. The hyperekplexia mutation increased the positive cooperativity of 0.3 mM propofol and glycine binding by about six times: the cooperativity factor β was 0.26 for α1 GlyRs and 0.04 for α1(R271L) GlyRs. Thus, propofol restored the potency of glycine impaired by the mutation. Five nortropeines, i.e. substituted benzoates of nortropine and a new compound, nortropisetron were prepared and also examined on [3H]strychnine binding. They showed nanomolar displacing potencies amplified by the hyperekplexia mutation. The affinity of nor-O-zatosetron (2.6 nM) is one of the highest reported for GlyRs. This binding test offers an in vitro method to evaluate agents against neurological disorders associated with inherited mutations of GlyRs.

Original languageEnglish
Pages (from-to)235-240
Number of pages6
JournalNeurochemistry International
Volume52
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Glycine Receptors
Strychnine
Propofol
Glycine
Mutation
zatosetron
Benzoates
Nervous System Diseases
Hyperekplexia
Kidney

Keywords

  • [H]strychnine binding
  • Hyperekplexia mutation
  • Propofol
  • Recombinant α glycine receptors
  • Ternary allosteric model
  • Tropeines

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Hyperekplexia mutation R271L of α1 glycine receptors potentiates allosteric interactions of nortropeines, propofol and glycine with [3H]strychnine binding. / Maksay, G.; Bíró, Tímea; Laube, Bodo; Nemes, Péter.

In: Neurochemistry International, Vol. 52, No. 1, 01.2008, p. 235-240.

Research output: Contribution to journalArticle

@article{ea581e9fc1fe44c5ad1377bfd00c93f2,
title = "Hyperekplexia mutation R271L of α1 glycine receptors potentiates allosteric interactions of nortropeines, propofol and glycine with [3H]strychnine binding",
abstract = "Human α1 and hyperekplexia mutant α1(R271L) glycine receptors (GlyRs) were transiently expressed in human embryonic kidney 293 cells for [3H]strychnine binding. Binding parameters were determined using a ternary allosteric model. The hyperekplexia mutation increased the positive cooperativity of 0.3 mM propofol and glycine binding by about six times: the cooperativity factor β was 0.26 for α1 GlyRs and 0.04 for α1(R271L) GlyRs. Thus, propofol restored the potency of glycine impaired by the mutation. Five nortropeines, i.e. substituted benzoates of nortropine and a new compound, nortropisetron were prepared and also examined on [3H]strychnine binding. They showed nanomolar displacing potencies amplified by the hyperekplexia mutation. The affinity of nor-O-zatosetron (2.6 nM) is one of the highest reported for GlyRs. This binding test offers an in vitro method to evaluate agents against neurological disorders associated with inherited mutations of GlyRs.",
keywords = "[H]strychnine binding, Hyperekplexia mutation, Propofol, Recombinant α glycine receptors, Ternary allosteric model, Tropeines",
author = "G. Maksay and T{\'i}mea B{\'i}r{\'o} and Bodo Laube and P{\'e}ter Nemes",
year = "2008",
month = "1",
doi = "10.1016/j.neuint.2007.06.009",
language = "English",
volume = "52",
pages = "235--240",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Hyperekplexia mutation R271L of α1 glycine receptors potentiates allosteric interactions of nortropeines, propofol and glycine with [3H]strychnine binding

AU - Maksay, G.

AU - Bíró, Tímea

AU - Laube, Bodo

AU - Nemes, Péter

PY - 2008/1

Y1 - 2008/1

N2 - Human α1 and hyperekplexia mutant α1(R271L) glycine receptors (GlyRs) were transiently expressed in human embryonic kidney 293 cells for [3H]strychnine binding. Binding parameters were determined using a ternary allosteric model. The hyperekplexia mutation increased the positive cooperativity of 0.3 mM propofol and glycine binding by about six times: the cooperativity factor β was 0.26 for α1 GlyRs and 0.04 for α1(R271L) GlyRs. Thus, propofol restored the potency of glycine impaired by the mutation. Five nortropeines, i.e. substituted benzoates of nortropine and a new compound, nortropisetron were prepared and also examined on [3H]strychnine binding. They showed nanomolar displacing potencies amplified by the hyperekplexia mutation. The affinity of nor-O-zatosetron (2.6 nM) is one of the highest reported for GlyRs. This binding test offers an in vitro method to evaluate agents against neurological disorders associated with inherited mutations of GlyRs.

AB - Human α1 and hyperekplexia mutant α1(R271L) glycine receptors (GlyRs) were transiently expressed in human embryonic kidney 293 cells for [3H]strychnine binding. Binding parameters were determined using a ternary allosteric model. The hyperekplexia mutation increased the positive cooperativity of 0.3 mM propofol and glycine binding by about six times: the cooperativity factor β was 0.26 for α1 GlyRs and 0.04 for α1(R271L) GlyRs. Thus, propofol restored the potency of glycine impaired by the mutation. Five nortropeines, i.e. substituted benzoates of nortropine and a new compound, nortropisetron were prepared and also examined on [3H]strychnine binding. They showed nanomolar displacing potencies amplified by the hyperekplexia mutation. The affinity of nor-O-zatosetron (2.6 nM) is one of the highest reported for GlyRs. This binding test offers an in vitro method to evaluate agents against neurological disorders associated with inherited mutations of GlyRs.

KW - [H]strychnine binding

KW - Hyperekplexia mutation

KW - Propofol

KW - Recombinant α glycine receptors

KW - Ternary allosteric model

KW - Tropeines

UR - http://www.scopus.com/inward/record.url?scp=36849056114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849056114&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2007.06.009

DO - 10.1016/j.neuint.2007.06.009

M3 - Article

C2 - 17655979

AN - SCOPUS:36849056114

VL - 52

SP - 235

EP - 240

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 1

ER -